Name | N-(5-Aminopentyl)-2-{[2-(2,6-dioxo-3-piperidinyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide |
---|---|
Synonyms |
Acetamide, N-(5-aminopentyl)-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
N-(5-Aminopentyl)-2-{[2-(2,6-dioxo-3-piperidinyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetamide |
Description | Thalidomide-O-amide-C5-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
---|---|
Related Catalog | |
Target |
Cereblon |
In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 757.3±60.0 °C at 760 mmHg |
Molecular Formula | C20H24N4O6 |
Molecular Weight | 416.428 |
Flash Point | 411.8±32.9 °C |
Exact Mass | 416.169586 |
LogP | -0.48 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |
Index of Refraction | 1.599 |
Hazard Codes | Xi |
---|